Lybalvi, a combination of olanzapine and samidorphan, is an antipsychotic medication designed to treat specific mental health conditions in adults. Lybalvi was approved by the U.S. Food and Drug Administration (FDA) on May 28, 2021.
Kiniksa Pharmaceuticals International announced that it has begun enrolling participants for the Phase 2b clinical trial of abiprubart in Sjögren’s Disease.
Sotorasib, marketed under the brand name Lumakras, is a medication designed to treat non-small cell lung cancer (NSCLC). Sotorasib was granted FDA approval on May 28, 2021.
AEON Biopharma revealed their intention to proceed with a crucial clinical development trial in cervical dystonia for their main product, ABP-450 (prabotulinumtoxinA) injection.
Jul 12st latest updates in the global new drug development field, including progress in new drug research and development, transaction information, and partnership developments.
Jul 11th latest updates in the global new drug development field, including progress in new drug research and development, transaction information, and partnership developments.